How many drugs treat Pityriasis simplex?

Drug Landscape tracks 7 marketed treatments for Pityriasis simplex (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/pityriasis-simplex.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Pityriasis simplex — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pityriasis simplex (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pityriasis simplex, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Loprox	CICLOPIROX	Bausch Health	ciclopirox	Poly [ADP-ribose] polymerase 1	1982-01-01
Nizoral	ketoconazole	Johnson & Johnson (Janssen)	Azole Antifungal [EPC]	Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1	1981-06-26
Derma-Smoothe/Fs	FLUOCINOLONE ACETONIDE	Eurofarma	Corticosteroid [EPC]	Glucocorticoid receptor	1963-01-01
Selsun	SELENIUM SULFIDE	Chattem	selenium sulfide		1951-01-01
Klaron	SULFACETAMIDE	Merck & Co.	Sulfonamide Antibacterial	Dihydrofolate reductase	1945-01-01
SULFUR	SULFUR	Poythress	sulfur	Carbonic anhydrase 1	1940-01-01
Penlac	Penlac	9305-9954 Quebec Inc		Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 5 drugs in Pityriasis simplex
9305-9954 Quebec Inc · 1 drug in Pityriasis simplex
Bausch Health · 1 drug in Pityriasis simplex
Chattem · 1 drug in Pityriasis simplex
Eurofarma · 1 drug in Pityriasis simplex
Johnson & Johnson (Janssen) · 1 drug in Pityriasis simplex
Merck & Co. · 1 drug in Pityriasis simplex
Poythress · 1 drug in Pityriasis simplex

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pityriasis simplex:

Cite this brief

Drug Landscape (2026). Pityriasis simplex — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pityriasis-simplex. Accessed 2026-06-10.

Pityriasis simplex full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing